Med Life S.A.
- Address
- lock Available on a paid plan
Med Life S.A. - Respiratory Research Center
Med Life S.A. is a clinical research facility specializing in respiratory medicine, with particular expertise in chronic pulmonary conditions. The center focuses on evaluating innovative therapeutic interventions for patients with complex airway diseases, contributing to the advancement of treatment options for challenging respiratory disorders.
- Bronchiectasis clinical trials and pulmonary exacerbation prevention
- Novel pharmacological interventions for chronic respiratory diseases
- Long-term respiratory disease management and outcomes research
The research team at Med Life S.A. is actively engaged in Phase III clinical investigations, including the AIRTIVITY® Study, which evaluates the efficacy of BI 1291583 in reducing pulmonary exacerbations in patients with bronchiectasis. This work demonstrates the center's commitment to addressing unmet medical needs in respiratory care and improving quality of life for patients living with chronic lung conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Med Life S.A.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of BI 1291583 in Patients with Bronchiectasis: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial | Boehringer Ingelheim Espana S.A., Boehringer Ingelheim International GmbH | Phase III | Recruiting | Aug 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 1291583 | 1 | Unknown | 2025-08-21 | 2025-08-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.